These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6515777)

  • 21. [Esophageal changes in scleroderma].
    Pisani M; Del Genio A
    G Ital Dermatol Venereol; 1984; 119(4):281-6. PubMed ID: 6490104
    [No Abstract]   [Full Text] [Related]  

  • 22. [Progressive systemic sclerosis (scleroderma) of the esophagus. A radiologic assessment].
    Dirksen KL; Hendel L; Brun B
    Ugeskr Laeger; 1984 May; 146(22):1641-3. PubMed ID: 6515776
    [No Abstract]   [Full Text] [Related]  

  • 23. Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud's disease.
    Weihrauch TR; Korting GW
    Br J Dermatol; 1982 Sep; 107(3):325-32. PubMed ID: 7115611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Esophageal involvement in progressive systemic sclerosis].
    Corti RE; Outeda JL; Corti RN; Copello A
    Arq Gastroenterol; 1982; 19(2):64-72. PubMed ID: 7185355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early changes in oesophageal function in progressive systemic sclerosis: a comparison of manometry and radiology.
    Blom-Bülow B; Sundström G; Jonson B; Tylén U; Wollheim FA
    Clin Physiol; 1984 Apr; 4(2):147-58. PubMed ID: 6539186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of esophageal manometry in the diagnosis and developmental control of scleroderma].
    Balanzoni S; Bagioni P; Bacchilega R; Catrani S
    Minerva Dietol Gastroenterol; 1985; 31(2):183-90. PubMed ID: 4034026
    [No Abstract]   [Full Text] [Related]  

  • 27. Oesophageal motility and lower oesophageal sphincter competence in progressive systemic sclerosis and localized scleroderma.
    Zaninotto G; Peserico A; Costantini M; Salvador L; Rondinone R; Roveran A; Piasentin G; Glorioso S; Merigliano S; Ancona E
    Scand J Gastroenterol; 1989 Jan; 24(1):95-102. PubMed ID: 2928728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radionuclide esophageal transit studies in progressive systemic sclerosis: an analysis of longitudinal data.
    Baron M; Arzoumanian A
    J Rheumatol; 1991 Dec; 18(12):1837-40. PubMed ID: 1795321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gastrointestinal involvement in progressive systemic sclerosis].
    Alvarez MG; Rubaldo RE; Kerzberg EM; De Paula A; Huberman ED
    Acta Gastroenterol Latinoam; 1984; 14(4):295-302. PubMed ID: 6537704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Motility disorders of the esophagus in progressive systemic scleroderma. Pathophysiology, diagnosis and therapy].
    Feussner H; Kreis M; Weiser HF
    Hautarzt; 1988 May; 39(5):291-7. PubMed ID: 3042699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Esophageal manometry and pH-monitoring in surgical indications].
    Di Gesù G; Bonventre S
    Minerva Chir; 1991 Apr; 46(7 Suppl):181-7. PubMed ID: 2067679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Round table: Scleroderma and esophageal changes].
    Abbati A; Andrieri D; Ballardini G; Bassi F; Bersani G; Bianchi FB; Bortolotti M; Bragaglia RB; Brusori S; De Vito M
    G Ital Dermatol Venereol; 1984; 119(4):233-61. PubMed ID: 6490098
    [No Abstract]   [Full Text] [Related]  

  • 33. [Functional study of the esophagus in progressive systemic sclerosis: utility of the manometry].
    Foggi E; Spaggiari L; Carbognani P; Rusca M; Soliani P; Dell'Abate P
    Acta Biomed Ateneo Parmense; 1991; 62(5-6):155-60. PubMed ID: 1844190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined long-term (24 hours) esophagogastric pH measurement in studying scleroderma patients].
    Fei L; Di Martino N; Amato G; Landolfi V; Ambrosio A; Cosenza A; Del Genio A
    Minerva Med; 1986 Mar; 77(12):441-6. PubMed ID: 3703336
    [No Abstract]   [Full Text] [Related]  

  • 35. The pattern of esophageal manometry in progressive systemic sclerosis.
    Al-Amri SM
    Saudi Med J; 2003 Jan; 24(1):68-71. PubMed ID: 12590279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anorectal motility in systemic scleroderma].
    Frieling T; Enck P; Bremer G; Lübke HJ; Berges W; Wienbeck M
    Z Gastroenterol; 1988 Nov; 26(11):689-93. PubMed ID: 3201810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Esophageal involvement in slceroderma: manometric study].
    Benages A; Cosin JA; Marqués E; Ridocci MT; Mora F; Molina R
    Rev Clin Esp; 1976 Mar; 140(5):457-63. PubMed ID: 935572
    [No Abstract]   [Full Text] [Related]  

  • 38. Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities.
    Johnson DA; Drane WE; Curran J; Benjamin SB; Chobanian SJ; Karvelis K; Cattau EL
    Arch Intern Med; 1987 Sep; 147(9):1597-601. PubMed ID: 3632168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis.
    Maddern GJ; Horowitz M; Jamieson GG; Chatterton BE; Collins PJ; Roberts-Thomson P
    Gastroenterology; 1984 Oct; 87(4):922-6. PubMed ID: 6468880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinico-manometric correlation in esophageal involvement of progressive systemic sclerosis].
    Corti RE; Outeda JL; Naveiro JJ; Nicolino D; Corti RN; Crosetti E
    Acta Gastroenterol Latinoam; 1982; 12(1):1-9. PubMed ID: 7136451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.